These models are suitable for implementation in almost any medical facility and can effectively discriminate liver fibrosis and cirrhosis in both treatment-naïve individuals (including those with ALT < 2× the upper limit of normal [ULN]) and treated CHB patients who have discontinued antiviral therapy in China. Here, GPT is linked to Hepatic fibrosis.